NextBioMedical Co

NextBioMedical Co EBIT per Share

The EBIT per Share of NextBioMedical Co (389650.KQ) as of Oct 5, 2026 is -88.54 KRW. In the previous year, EBIT per Share was 187.43 KRW — a change of -147.24% (lower).

EBIT per Share

-88.54KRW

YoY

-147.24%

Last updated:

EBIT per Share of NextBioMedical Co is 2026 -88.54 KRW. EBIT per Share of NextBioMedical Co was 2025 187.43 KRW. It decreases by -147.24% lower compared to the previous year.

The NextBioMedical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-870.39 KRW
Jan 1, 2022
-607.13 KRW
Jan 1, 2023
-955.54 KRW
Jan 1, 2024
187.43 KRW
Jan 1, 2025
-88.54 KRW
Jan 1, 2026 (e)
437.43 KRW
Jan 1, 2027 (e)
1,296.68 KRW
The NextBioMedical Co EBIT per Share history
YEAREBIT per ShareYoY
est1,296.68KRW+196.43%
est437.43KRW-594.07%
-88.54KRW-147.24%
187.43KRW-119.61%
-955.54KRW+57.39%
-607.13KRW-30.25%
-870.39KRW—
Access this data via the Eulerpool API
Get Free API Key

NextBioMedical Co Stock analysis

What does NextBioMedical Co do? NextBioMedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NextBioMedical Co stock

EBIT per Share of NextBioMedical Co is -88.54 KRW in 2026.

EBIT per Share of NextBioMedical Co changed from 187.43 KRW to -88.54 KRW, representing a -147.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share NextBioMedical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NextBioMedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NextBioMedical Co